Concepedia

Author

Jiuxiang Zhu

The Ohio State University

Also Known As

Jiuxiang Zhu

29

Publications

1.2K

Citations

11

H-Index

28

Concepts

All Affiliations

The Ohio State UniversityHoward Hughes Medical InstituteSidney Kimmel Cancer CenterCancer Genetics (United States)Johns Hopkins University
JZ

About

Jiuxiang Zhu is an author at The Ohio State University specializing in medicine, cellular biochemistry, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

477

2

Natural Sciences

2

2

340

3

Biochemistry

2

2

75

4

Cell Biology

2

2

402

5

Cellular Physiology

1

1

292

Jiuxiang Zhu

×

11

Publications

1.2K

Citations

11

H-Index

YearCitations

A frequent kinase domain mutation that changes the interaction between PI3Kα and the membrane

Diana Mandelker, Sandra B. Gabelli, Oleg Schmidt‐Kittler,

Proceedings of the National Academy of Sciences

2009

292

From the Cyclooxygenase-2 Inhibitor Celecoxib to a Novel Class of 3-Phosphoinositide-Dependent Protein Kinase-1 Inhibitors

Jiuxiang Zhu, Jui-Wen Huang, Ping‐Hui Tseng,

Cancer Research

2004

255

Neutrophil gelatinase-associated lipocalin as a survival factor

Zhimin Tong, Xuli Wu, Dmitriy Ovcharenko,

Biochemical Journal

2005

181

Celecoxib derivatives induce apoptosis <i>via</i> the disruption of mitochondrial membrane potential and activation of caspase 9

Haiming Ding, Chunhua Han, Jiuxiang Zhu,

International Journal of Cancer

2004

110

Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours

Jill E. Kucab, Cathy Lee, Ching‐Shih Chen,

Breast Cancer Research

2005

93

A novel celecoxib derivative, OSU03012, induces cytotoxicity in primary CLL cells and transformed B-cell lymphoma cell line via a caspase- and Bcl-2–independent mechanism

Amy J. Johnson, Lisa L. Smith, Jiuxiang Zhu,

Blood

2004

68

Synergistic interactions between imatinib mesylate and the novel phosphoinositide-dependent kinase-1 inhibitor OSU-03012 in overcoming imatinib mesylate resistance

Ping‐Hui Tseng, Ho-Pi Lin, Jiuxiang Zhu,

Blood

2005

67

Dissecting isoform selectivity of PI3K inhibitors: the role of non-conserved residues in the catalytic pocket

Mark Frazzetto, Cenk Suphioglu, Jiuxiang Zhu,

Biochemical Journal

2008

48

PI3Kα Inhibitors That Inhibit Metastasis

Oleg Schmidt‐Kittler, Jiuxiang Zhu, Jian Yang,

Oncotarget

2010

40

Definition of the binding mode of a new class of phosphoinositide 3-kinase α-selective inhibitors using <i>in vitro</i> mutagenesis of non-conserved amino acids and kinetic analysis

Zhaohua Zheng, Syazwani Itri Amran, Jiuxiang Zhu,

Biochemical Journal

2012

27

Page 1